AstraZeneca Stock Latest News

The European Commission (EC) has approved global pharmaceutical company AstraZeneca PLC’s (AZN) Ultomiris (ravulizumab) to treat adolescents and...

The U.K. Competition and Markets Authority has given AstraZeneca (AZN) the green light to proceed with its acquisition...

The South Korean government is in talks with Moderna (MRNA) and Pfizer (PFE) about manufacturing their COVID-19 vaccines...

Fusion Pharmaceuticals (FUSN) has teamed up with McMaster University to set up a radiopharmaceutical manufacturing facility in Hamilton....

AstraZeneca (AZN) is collaborating with biotech company Alchemab on prostate cancer research. The two companies will work on...

AstraZeneca (AZN) has received approval from the U.S. Food and Drug Administration (FDA) for its sodium-glucose cotransporter 2...

By now you’ve heard the news. On Tuesday, April 13, the U.S. Centers for Disease Control and Food...

AstraZeneca announced yesterday that the World Health Organization (WHO) has granted an Emergency Use Listing (EUL) for its...

The new coronavirus mutant strains are playing havoc with the already approved Covid-19 vaccines. The latest data shows...

The Astrazeneca/Oxford vaccine offers only limited protection against mild disease caused by the South African variant of the...

AstraZeneca will start to supply the European Union with an additional 9 million doses of its vaccine after...

AstraZeneca Plc’s and Daiichi Sankyo Co Ltd.’s drug Enhertu (trastuzumab) has won approval in the US to be used...

The COVID-19 vaccine developed by AstraZeneca and Oxford University has been approved by the Indian drug regulator for...

AstraZeneca will start to supply the UK with its COVID-19 vaccine after the country was first to approve...

AstraZeneca and MSD’s (Merck (MRK) is known as MSD outside the US and Canada) Lynparza (olaparib) has been...

AstraZeneca’s COVID-19 vaccine will be effective against the new variant of the virus, the company’s CEO, Pascal Soriot,...

AstraZeneca announced that it has received US regulatory approval for its Tagrisso treatment used for patients with non-small-cell...

AstraZeneca announced that it has agreed to acquire US drugmaker Alexion Pharmaceuticals in a cash and stock deal...

AstraZeneca has agreed to sell the rights to its cholesterol drug Crestor and associated medicines in over 30 countries...

AstraZeneca Plc is likely to do another global trial to assess the efficiency of its COVID-19 vaccine as...

AstraZeneca said that its coronavirus vaccine candidate, which it is developing together with Oxford University, has shown an...

AstraZeneca’s coronavirus vaccine candidate, which it is developing together with Oxford University, induced a strong immune response in...

Amgen (AMGN) and AstraZeneca (AZN) have announced positive topline results from the Phase 3 Navigator trial for tezepelumab,...

AstraZeneca announced that the US regulator has approved its heart treatment Brilinta to be used to reduce the...

AstraZeneca will present late-stage trial data for its Covid-19 vaccine candidate later this year as the UK drugmaker...

AstraZeneca on Friday announced that it would sell the commercial rights to two hypertension medicines, Atacand and Atacand...

Astrazeneca Pharmaceuticals (AZN) has been awarded a $286.9 milllion firm-fixed-price contract for the delivery of 200 million doses...

AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has authorized the restart of the...

A Brazilian volunteer taking part in a COVID-19 clinical trial by AstraZeneca and Oxford University has died, Reuters...

AstraZeneca’s US Covid-19 vaccine trial is poised to resume as early as this week after the US Food...

AstraZeneca announced on Monday that the European Medicines Agency (EMA) has put forward recommendations to approve Forxiga, its...

AstraZeneca has secured $486m from the US Government for the development and supply of 100,000 doses of its...

AstraZeneca’s Covid-19 candidate AZD1222 has been put under a rolling review by the European Medicines Agency (EMA), which...

Does AstraZeneca (AZN) still have a fighting chance in the COVID-19 vaccine race? Earlier this month, the healthcare...

AstraZeneca announced that its Lynparza drug has been recommended for marketing authorization in the European Union (EU) for patients...

AstraZeneca said that additional data from the Phase 3 trial of its Imfinzi treatment showed “unprecedented” survival in...

AstraZeneca’s (AZN) Covid-19 vaccine trial is on pause in the United States pending a US investigation into a suspected...

Phase three trials for the AstraZeneca (AZN)/ Oxford coronavirus vaccine, AZD1222, have now resumed in the UK following...

AstraZeneca announced on Thursday that its Fasenra asthma therapy used in the treatment for a chronic inflammatory disease...

Just eight days after AstraZeneca (AZN) announced the expansion of clinical trials of its AZD1222 vaccine against coronavirus...

Shares in AstraZeneca (AZN) plunged 8% in Tuesday’s after-hours trading after the biopharma put its late-stage Covid-19 vaccine...

Speaking on British national news radio station LBC, UK health secretary Matt Hancock on Monday said that AstraZeneca’s...

Dr. Reddy’s Laboratories (RDY) has announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose...

Australia has announced a $1.2 billion supply and production agreement for over 84.8 million Covid-19 vaccine doses with...

Oxford Biomedica announced on Monday that it has signed an 18-month supply agreement with AstraZeneca for large-scale commercial...

AstraZeneca announced that it has started enrolling adults for a Phase 3 clinical trial in the US of its...

AstraZeneca announced on Tuesday that it has initiated an early study trial of AZD7442, a combination of two...

Shares in AstraZeneca are advancing in the pre-market session amid a report that the Trump administration is considering...

UK biopharma AstraZeneca (AZN) has now received regulatory approval to hold part of a late-stage trial for its...

AstraZeneca (AZN) has announced that its Imfinzi (durvalumab) treatment has been approved in Japan for extensive-stage small cell...